Patients who receive certain cancer treatments are at greater risk of secondary malignancies and must be educated accordingly ...

The FDA approved tislelizumab-jsgr (Tevimbra) with platinum chemotherapy as a first-line treatment for adults with ...

Hazards of the LA wildfires necessitate awareness that first responders and those central to the fires may be at risk for ...

Oncology nurses are familiar with the concept of financial toxicity, which refers to the significant financial burden cancer ...

Avelumab in combination with axitinib was found effective and safe as frontline treatment for advanced RCC in real-world ...

Katy Beckermann, MD, PhD, explained that oncology nurses and APPs should be ready to administer and explain dose ...

Axel Stuart Merseburger, MD, PhD, explained that with TKIs like axitinib, it is necessary for oncology nurses to spend time ...

AUTX-703, a novel, oral KAT2A/B degrader, has received fast track designation for use in relapsed/refractory AML.

According to Laurence Albiges, MD, PhD, treatment of RCC with cabozantinib, nivolumab, and ipilimumab can cause potentially ...

C, BSN, RN, discussed taking advantage of available resources to provide comprehensive care for patients with breast cancer.

Panelists discuss how emerging treatments, digital health tools, and enhanced care coordination could streamline disease ...

Immune checkpoint inhibitors for patients with cancer may be associated with an increased risk for psoriasis when compared ...